Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

TALPHERA, INC. Director's Dealing 2021

Nov 23, 2021

35181_dirs_2021-11-23_6ef2d77b-10d3-4f52-a587-cfb5bbef45ea.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2021-11-20

Reporting Person: Broadfoot Jill Marie (Director)

More from TALPHERA, INC.

Interim / Quarterly Report 2026
May 13
Proxy Solicitation & Information Statement 2026
Apr 29
Director's Dealing 2026
Mar 26
Regulatory Filings 2026
Mar 23
Director's Dealing 2026
Mar 17
Director's Dealing 2026
Feb 21
Director's Dealing 2026
Feb 21
Director's Dealing 2026
Feb 21
Director's Dealing 2026
Feb 21
Major Shareholding Notification 2026
Feb 17
View all filings →